BibTex RIS Kaynak Göster

Sağlık Hizmetlerinde Önceliklerin Belirlenmesinde Ekonomik Değerlendirme Yöntemi Olarak Maliyet-Etkililik Analizi

Yıl 2009, Cilt: 14 Sayı: 2, 311 - 332, 01.06.2009

  Yrd.Doç.Dr.Zafer Çalışkan

Öz

Anahtar Kelimeler

-

Kaynakça

  • ANELL, A. “Priority setting for pharmaceuticals: the use of health economic evidence by reimbursement and clinical guidance committees” The European Journal of Health Economics, Vol. 5 (1), 2004, s. 2835.
  • BALTUSSEN, R. “Priority setting of public spending in developing countries: Do not try to do everything for everybody”, Health Policy, 78, 2006, s. 149–156.
  • BALTUSSEN, R. ve NIESSEN, L. “Priority setting of health interventions: the need for multi-criteria decision analysis”, Cost Effectiveness and Resource Allocation, 4:14, 2006, s. 1-9.
  • BROUWER, W. B. F. vd. “Welfarism vs. extra-welfarism”, Journal of Health Economics, 27, 2008, s. 325-338.
  • COAST, J. “Is economic evaluation in touch with society's health values?”, British Medical Journal, 329, 2004, s. 1233-1236.
  • COAST, J. vd. “Welfarism, extra-welfarism and capability: The spread of ideas in health economics”, Social Science and Medicine, 67, 2008, s. 1190-1198.
  • CORNAGO, D. vd. “Pharmacoeconomic studies in Italy: a critical review of the literature”, The European Journal of Health Economics, Vol. 8, 2007, s. 89-95.
  • CORNUZ, J. vd. “Cost-effectiveness analysis of the first-line therapies for nicotine dependence”, European Journal of Clinical Pharmacology, 59 (3), 2003, s. 201-206.
  • COX, H. L. “Economic evaluation in critical care medicine”, Journal of Critical Care, 21, 2006, s. 117-124.
  • CUNNINGHAM, S. J. “Economic evaluation of healthcare - is it important to us?”, British Dental Journal, Vol.188 (5), 2000, s. 250254.
  • DRUMMOND, M. F. vd. Methods for the Economic Evaluation of Health Care Programmes, New York, Oxford Medical Publications, 2005.
  • DRUMMOND, M. F. vd. “Economic evaluation”, Singapore Med. Journal, 47(6), 2006, s. 456-461.
  • FOLLAND, S. vd. The Economics of Health and Health Care, New York, Pearson Prentice Hall, 2006.
  • FOX-RUSHBY, J. A., ve HANSON, K. “Calculating and presenting disability adjusted life years (DALYs) in cost-effective analysis”, Health Policy and Planning, 16 (3), 2001, s. 326-331.
  • GAFNI, A. ve BIRCH, S. “Incremental cost-effectiveness ratios (ICERs): The silence of the lambda” Social Science and Medicine, 62, 2006, s. 2091-2100.
  • GARBER, A. “Advances in cost-effectiveness analysis of health interventions”, NBER Working Paper Series, No: 7198, 1999, http://www.nber.org/papers/w7198.
  • GARBER, A. M. ve PHELPS, C. E. “Economic foundations of costeffectiveness analysis”, Journal of Health Economics, 16, 1997, s. 131.
  • GOODACRE, S. ve McCABE, C. “An introduction to economic evaluation”, The Emergency Medicine Journal, 19, 2002, s. 198-201.
  • HAM, C. “Priority setting in health care: learning from international experience”, Health Policy, 42, 1997, s. 49-66.
  • HAUCK, K. vd. “The Economics of Priority Setting for Health Care: A Literature Review”, HNP Discussion Paper, Washington, The World Bank. 2004.
  • HURLEY, J. “An Overview of the Normative Economics of the Health Sector”, Culyer, A. J. ve Newhouse, J. P. (der.) Handbook of Health Economics içinde, Elsevier, Amsterdam, 2000, s. 55-110.
  • JÖNSSON, B. “Economic evaluation for pharmaceuticals in Germany”, The European Journal of Health Economics, 8 (Suppl. 1), 2007, s. 12.
  • KAMATH, C. C. vd. “The Cost-effectiveness of acetaminophen, NSAIDs, and selective COX-2 inhibitors in the treatment of symptomatic knee osteoarthritis”, Value in Health, Vol. 6 (2), 2001, s.144-157.
  • KAPIRIRI, L. ve NORHEIM, O. F. “Criteria for priority-setting in health care in Uganda: exploration of stakeholders’ values”, Bulletin of the World Health Organization, 82 (3), 2004, s. 172-179.
  • KERNICK, D. “An introduction to the basic principles of health economics for those involved in the development and delivery of headache care”, Cephalalgia, 25, 2005, s. 709–714.
  • KLARMAN, H. E. vd. “Cost-effectiveness analysis applied to the treatment of chronic renal disease”, Medical Care, 6, 1968, s. 48–54.
  • KORTHALS-DE BOS, I. B. C. vd. “Cost-effectiveness of physiotherapy, manual therapy, and general practitioner care for neck pain: economic evaluation alongside a randomized controlled trial”, British Medical Journal, Vol. 326, 2003, s. 1-6.
  • MELTZER, D. “Accounting for future costs in medical costeffectiveness analysis”, Journal of Health Economics, 16 (1), 1997, s. 33-64.
  • MITTON, C. R. “Priority setting for decision makers: using health economics in practice”, The European Journal of Health Economics, Vol. 3, No. 4, 2002, s. 240-243.
  • OECD Health a Glance OECD Indicators, Geneva, OECD, 2007.
  • PLEVRITIS, S. K. vd. “Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs. X-ray mammography of women at a high familial risk of breast cancer”, British Journal of Cancer, 95, 2006, s. 801-810.
  • ROBERTSON, M. C. vd “Effectiveness and economic evaluation of a nurse delivered home exercise programme to prevent falls. 1: Randomized controlled trial”, British Medical Journal, Vol. 322, 2001, s. 1-6.
  • ROBINSON, R. “Limits to rationality: economics, economists and priority setting”, Health Policy, 49, 1999, s. 13-26.
  • SABIK, L.M. ve LIE, K. R. “Priority setting in health care: Lessons from the experiences of eight countries”, International Journal for Equity in Health, 7:4, 2008, s. 1-13.
  • SCULPHER, M. vd. “It’s just evaluation for decision making: recent developments in, and challenges for, cost-effectiveness research”, Smith, P. C. vd. (der.) Health Policy and Economics: Opportunities and Challenges içinde, McGrawHill, Glasgow, 2005, s. 8-41.
  • VERKERK, M. A. vd “Health-related quality of life research and the capability approach of Amartya Sen”, Quality of Life Research, Vol. 10 (1), 2001, s. 49-55.
  • WEINSTEIN, M. C. ve MANNING, W. G. Jr. “Theoretical issues in cost-effectiveness analysis”, Journal of Health Economics, 16, 1997, s. 121-128.
  • WHO The World Health Report 2000 - Health Systems: Improving Performance, WHO, Geneva, 2000.

SAĞLIK HİZMETLERİNDE ÖNCELİKLERİN BELİRLENMESİNDE EKONOMİK DEĞERLENDİRME YÖNTEMİ OLARAK MALİYET-ETKİLİLİK ANALİZİ

Yıl 2009, Cilt: 14 Sayı: 2, 311 - 332, 01.06.2009

  Yrd.Doç.Dr.Zafer Çalışkan

Öz

Sağlık hizmetlerine olan ihtiyacın artması ve bu alana ayrılan kaynakların sınırlı olması nedeniyle, hangi sağlık programlarına ya da teknolojilerine öncelik verileceği önemli hale gelmiştir. Bu yüzden önceliklerin belirlenmesinde ekonomik değerlendirme yöntemleri karar vericilere önemli bilgiler sunduğu ve belirsizliği önemli ölçüde azalttığı için yaygın olarak kullanılmaya başlanmıştır. Literatürde birden çok yöntem bulunmaktadır. Bu yöntemlerden maliyet-etkililik analizi bir sağlık programının maliyet ve sonuçlarını birlikte değerlendirdiğinden yaygın olarak kullanılmaktadır. Dolayısıyla, bu çalışmada önceliklerin belirlenmesi süreci ile bu süreçte kriterlerden biri olarak kabul edilen maliyet-etkililik analizi ve uygulama alanları sunulmaktadır

Anahtar Kelimeler

Önceliklerin belirlenmesi Ekonomik değerlendirme Maliyet-etkililik

Kaynakça

  • ANELL, A. “Priority setting for pharmaceuticals: the use of health economic evidence by reimbursement and clinical guidance committees” The European Journal of Health Economics, Vol. 5 (1), 2004, s. 2835.
  • BALTUSSEN, R. “Priority setting of public spending in developing countries: Do not try to do everything for everybody”, Health Policy, 78, 2006, s. 149–156.
  • BALTUSSEN, R. ve NIESSEN, L. “Priority setting of health interventions: the need for multi-criteria decision analysis”, Cost Effectiveness and Resource Allocation, 4:14, 2006, s. 1-9.
  • BROUWER, W. B. F. vd. “Welfarism vs. extra-welfarism”, Journal of Health Economics, 27, 2008, s. 325-338.
  • COAST, J. “Is economic evaluation in touch with society's health values?”, British Medical Journal, 329, 2004, s. 1233-1236.
  • COAST, J. vd. “Welfarism, extra-welfarism and capability: The spread of ideas in health economics”, Social Science and Medicine, 67, 2008, s. 1190-1198.
  • CORNAGO, D. vd. “Pharmacoeconomic studies in Italy: a critical review of the literature”, The European Journal of Health Economics, Vol. 8, 2007, s. 89-95.
  • CORNUZ, J. vd. “Cost-effectiveness analysis of the first-line therapies for nicotine dependence”, European Journal of Clinical Pharmacology, 59 (3), 2003, s. 201-206.
  • COX, H. L. “Economic evaluation in critical care medicine”, Journal of Critical Care, 21, 2006, s. 117-124.
  • CUNNINGHAM, S. J. “Economic evaluation of healthcare - is it important to us?”, British Dental Journal, Vol.188 (5), 2000, s. 250254.
  • DRUMMOND, M. F. vd. Methods for the Economic Evaluation of Health Care Programmes, New York, Oxford Medical Publications, 2005.
  • DRUMMOND, M. F. vd. “Economic evaluation”, Singapore Med. Journal, 47(6), 2006, s. 456-461.
  • FOLLAND, S. vd. The Economics of Health and Health Care, New York, Pearson Prentice Hall, 2006.
  • FOX-RUSHBY, J. A., ve HANSON, K. “Calculating and presenting disability adjusted life years (DALYs) in cost-effective analysis”, Health Policy and Planning, 16 (3), 2001, s. 326-331.
  • GAFNI, A. ve BIRCH, S. “Incremental cost-effectiveness ratios (ICERs): The silence of the lambda” Social Science and Medicine, 62, 2006, s. 2091-2100.
  • GARBER, A. “Advances in cost-effectiveness analysis of health interventions”, NBER Working Paper Series, No: 7198, 1999, http://www.nber.org/papers/w7198.
  • GARBER, A. M. ve PHELPS, C. E. “Economic foundations of costeffectiveness analysis”, Journal of Health Economics, 16, 1997, s. 131.
  • GOODACRE, S. ve McCABE, C. “An introduction to economic evaluation”, The Emergency Medicine Journal, 19, 2002, s. 198-201.
  • HAM, C. “Priority setting in health care: learning from international experience”, Health Policy, 42, 1997, s. 49-66.
  • HAUCK, K. vd. “The Economics of Priority Setting for Health Care: A Literature Review”, HNP Discussion Paper, Washington, The World Bank. 2004.
  • HURLEY, J. “An Overview of the Normative Economics of the Health Sector”, Culyer, A. J. ve Newhouse, J. P. (der.) Handbook of Health Economics içinde, Elsevier, Amsterdam, 2000, s. 55-110.
  • JÖNSSON, B. “Economic evaluation for pharmaceuticals in Germany”, The European Journal of Health Economics, 8 (Suppl. 1), 2007, s. 12.
  • KAMATH, C. C. vd. “The Cost-effectiveness of acetaminophen, NSAIDs, and selective COX-2 inhibitors in the treatment of symptomatic knee osteoarthritis”, Value in Health, Vol. 6 (2), 2001, s.144-157.
  • KAPIRIRI, L. ve NORHEIM, O. F. “Criteria for priority-setting in health care in Uganda: exploration of stakeholders’ values”, Bulletin of the World Health Organization, 82 (3), 2004, s. 172-179.
  • KERNICK, D. “An introduction to the basic principles of health economics for those involved in the development and delivery of headache care”, Cephalalgia, 25, 2005, s. 709–714.
  • KLARMAN, H. E. vd. “Cost-effectiveness analysis applied to the treatment of chronic renal disease”, Medical Care, 6, 1968, s. 48–54.
  • KORTHALS-DE BOS, I. B. C. vd. “Cost-effectiveness of physiotherapy, manual therapy, and general practitioner care for neck pain: economic evaluation alongside a randomized controlled trial”, British Medical Journal, Vol. 326, 2003, s. 1-6.
  • MELTZER, D. “Accounting for future costs in medical costeffectiveness analysis”, Journal of Health Economics, 16 (1), 1997, s. 33-64.
  • MITTON, C. R. “Priority setting for decision makers: using health economics in practice”, The European Journal of Health Economics, Vol. 3, No. 4, 2002, s. 240-243.
  • OECD Health a Glance OECD Indicators, Geneva, OECD, 2007.
  • PLEVRITIS, S. K. vd. “Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs. X-ray mammography of women at a high familial risk of breast cancer”, British Journal of Cancer, 95, 2006, s. 801-810.
  • ROBERTSON, M. C. vd “Effectiveness and economic evaluation of a nurse delivered home exercise programme to prevent falls. 1: Randomized controlled trial”, British Medical Journal, Vol. 322, 2001, s. 1-6.
  • ROBINSON, R. “Limits to rationality: economics, economists and priority setting”, Health Policy, 49, 1999, s. 13-26.
  • SABIK, L.M. ve LIE, K. R. “Priority setting in health care: Lessons from the experiences of eight countries”, International Journal for Equity in Health, 7:4, 2008, s. 1-13.
  • SCULPHER, M. vd. “It’s just evaluation for decision making: recent developments in, and challenges for, cost-effectiveness research”, Smith, P. C. vd. (der.) Health Policy and Economics: Opportunities and Challenges içinde, McGrawHill, Glasgow, 2005, s. 8-41.
  • VERKERK, M. A. vd “Health-related quality of life research and the capability approach of Amartya Sen”, Quality of Life Research, Vol. 10 (1), 2001, s. 49-55.
  • WEINSTEIN, M. C. ve MANNING, W. G. Jr. “Theoretical issues in cost-effectiveness analysis”, Journal of Health Economics, 16, 1997, s. 121-128.
  • WHO The World Health Report 2000 - Health Systems: Improving Performance, WHO, Geneva, 2000.
Toplam 38 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Bölüm Makaleler
Yazarlar

  Yrd.Doç.Dr.Zafer Çalışkan Bu kişi benim

Yayımlanma Tarihi 1 Haziran 2009
Yayımlandığı Sayı Yıl 2009 Cilt: 14 Sayı: 2

Kaynak Göster

APA Çalışkan, .Y. (2009). SAĞLIK HİZMETLERİNDE ÖNCELİKLERİN BELİRLENMESİNDE EKONOMİK DEĞERLENDİRME YÖNTEMİ OLARAK MALİYET-ETKİLİLİK ANALİZİ. Süleyman Demirel Üniversitesi İktisadi Ve İdari Bilimler Fakültesi Dergisi, 14(2), 311-332.